Varicella vaccination: where do we go from here?
Although meager knowledge of the virus raises serious safety questions, the risk of death from varicella in immunocompromised children justifies further trials. In the meantime, passive immunization is a safe and relatively effective alternative.
D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis; D002644:Chickenpox / Q000517:prevention & control*; D002648:Child; D006562:Herpes Zoster / Q000517:prevention & control*; D014645:Herpesvirus 3, Human / Q000276:immunology*; D006801:Humans; D007106:Immune Sera / Q000008:administration & dosage; D007114:Immunization; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D007223:Infant; D007938:Leukemia / Q000188:drug therapy; D008875:Middle Aged; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000009:adverse effects
D000914:Antibodies, Viral; D007106:Immune Sera; D014765:Viral Vaccines